Ligand validation:4AWU

PE4: 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AWU_PE4_A_505	13%	62%	0.293	0.832	0.68	0.78	-	1	1	0	100%	1
4AWT_PE4_A_504	16%	58%	0.261	0.832	0.66	0.96	-	1	2	0	100%	1
2GOU_PE4_A_4124	1%	5%	0.35	0.55	0.5	4.61	-	12	0	0	100%	0.5417
3EBW_PE4_B_5747	87%	50%	0.086	0.973	0.76	1.16	-	1	3	0	92%	0.9167
4QIB_PE4_A_201	74%	58%	0.103	0.934	0.7	0.91	-	1	0	0	100%	1
4E0K_PE4_C_101	68%	44%	0.074	0.952	0.71	1.42	-	-	0	0	63%	18.12
4EWL_PE4_A_401	68%	57%	0.125	0.936	0.7	0.96	-	1	6	0	100%	0.9704
5UY9_PE4_A_300	66%	65%	0.123	0.927	0.5	0.82	-	1	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.